Featured Stories Title PDF Version Leading In Continued Innovation for Rare Diseases Leading in Tenacity, Grit and Curiosity to Deliver Rare Medicines Leading in Collaboration with the Rare Disease Ecosystem Leading in Patient Centricity in Rare Disease R&D Leading in Rare Regulatory Pathways Leading In Rare Disease Clinical Trials Leading in Rare Diseases for 30 Years: Pioneering Complement Science Then and Now Rare Disease Day 2022: Advancing the Conversation Around Health Equity New Book Series for Children Inspired by Patients The Complexity of “Happy Veterans Day” Embedding patient-centricity | LEAP (Learn, Evolve, Activate, and deliver for Patients) AstraZeneca Expands Role in Rare Disease by Acquiring Alexion Pharmaceuticals RARE ANSWERS™: A System to Improve Patient Outcomes Alexion Participates in Milken Institute’s Future of Health Summit Committed to Patients: Ensuring Continuity in a Global Pandemic Alexion’s Commitment To Sustaining Our Planet Listening And Learning From The Rare Disease Patient